The DOI matches its Crossref record; 164 of the 164 references it cites were found in a registry or an index.
Exaggerated Levothyroxine Malabsorption Due to Calcium Carbonate Supplementation in Gastrointestinal Disorders
Abstract
OBJECTIVE: To describe a patient with primary hypothyroidism in whom ingestion of levothyroxine with calcium carbonate led to markedly elevated serum thyrotropin concentrations. CASE SUMMARY: A 61-year-old white woman with primary hypothyroidism, systemic lupus erythematosus, celiac disease, and history of Whipple resection for pancreatic cancer was euthyroid with levothyroxine 175-188 micrograms/d. After taking a high dose of calcium carbonate (1250 mg three times daily) with levothyroxine, she developed biochemical evidence of hypothyroidism (thyrotropin up to 41.4 mU/L) while remaining clinically euthyroid. Delaying calcium carbonate administration by four hours returned her serum thyrotropin to a borderline high concentration (5.7 mU/L) within a month. Serum concentrations of unbound and total thyroxine and triiodothyronine tended to decrease, but remained borderline low to normal while the patient concomitantly received levothyroxine and calcium carbonate. DISCUSSION: Concomitant administration of levothyroxine and calcium carbonate often results in levothyroxine malabsorption. While in most patients the clinical consequences of this interaction, even with prolonged exposure, are relatively small, overt hypothyrodism may develop in patients with preexisting malabsorption disorders. However, as the current case illustrates, the clinical manifestations of the initial levothyroxine deficit may not always be apparent and, of all usual laboratory thyroid function tests, only thyrotropin measurement will reliably uncover the exaggerated levothyroxine malabsorption. CONCLUSIONS: Decreased absorption of levothyroxine when given with calcium carbonate may be particularly pronounced in patients with preexisting malabsorption disorders. Once recognized, a change in drug administration schedule usually minimizes or eliminates this interaction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, dramatic increases in serum TSH appear to be possible in patients with more than one factor contributing to impaired LT4 absorption, as occurred in a patient with both celiac disease and calcium carbonate use (162).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [162]
In the citing paper
“In contrast, a retrospective study of elderly nursing home residents showed that serum TSH values were unaffected when the timing of LT4 administration was changed from 9 am (1-2 hours after breakfast) compared with midnight (3 hours after a snack) (130).”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [130]
In the citing paper
“Four studies (121,126,128,129), out of the six studies examining this issue (121,128-131), have shown that the timing of LT4 administration influences the serum TSH values of hypothyroid patients receiving treatment.”
From Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement (2014) · cites this paper as [130]
In the citing paper
“Biological hypothyroidism is easily corrected a few days after withdrawal of drugs reducing intestinal absorption, while a longer time (weeks to months) is needed for drugs affecting in vivo metabolism (87, 94).”
From Levothyroxine: conventional and novel drug delivery formulations. (2023) · cites this paper as [94]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
(1998) · New England Journal of Medicine · doi:10.1056/nejm199811053391902 · Cited by 5,261
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439
Shimada, T., Yamazaki, H., Mimura, M., Inui, Y., & Guengerich, F. P. (1994) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22379-5 · Cited by 2,785
Handbook of Religion and Health
Koenig, H., McCullough, M., & Larson, D. (2001) · doi:10.1093/acprof:oso/9780195118667.001.0001 · Cited by 2,581
Self-citationMeta-analysis: Principles and procedures
Egger, M., Smith, G. D., & Phillips, A. N. (1997) · BMJ · doi:10.1136/bmj.315.7121.1533 · Cited by 2,415
Pharmacotherapy: A Pathophysiologic Approach
(1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-5-447_3 · Cited by 2,407
Valery (1995) · doi:10.1001/jama.1995.03520270033028 · Cited by 2,320
Research works printed but not linked: 5
- Kung AW, 1996, J Endocrinol Metab, 81, 1232
- 2000, Physicians' desk reference
- Franzese A, 1993, L-Thyroxine malabsorption determined by intolerance to cow's milk proteins and celiac disease in a patient with congenital hypothyroidism. A clinical case.] (Italian, 45, 113
- Valentino R, 1999, Horm Res, 51, 124
- Suzuki Y, 1982, Impaired intestinal absorption of thyroid hormone in a case of Hashimoto's disease with anti-T3 and anti-T4 antibody, 58, 1487
Cited by
Items 101–200 of 271
Safety issues and prospects for future generations of PPAR modulators
RUBENSTRUNK, A., HANF, R., HUM, D., FRUCHART, J., & STAELS, B. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2007.02.003 · Cited by 309
Clinical Utility of Bile Acid Sequestrants in the Treatment of Dyslipidemia: A Scientific Review
Insull, W. (2006) · Southern Medical Journal · doi:10.1097/01.smj.0000208120.73327.db · Cited by 308
Cox, E., Martin, B. C., Van Staa, T., Garbe, E., Siebert, U., & Johnson, M. L. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00601.x · Cited by 307
Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2024) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 302
Clinical pharmacology in the geriatric patient
Hilmer, S. N., McLachlan, A. J., & Le Couteur, D. G. (2007) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2007.00473.x · Cited by 296
Saad, A. H., DePestel, D. D., & Carver, P. L. (2006) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.26.12.1730 · Cited by 295
The effect of gemfibrozil on the pharmacokinetics of rosuvastatin
Schneck, D. (2004) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2003.12.014 · Cited by 292
Improved Postoperative Outcomes Associated with Preoperative Statin Therapy
Hindler, K., Shaw, A. D., Samuels, J., Fulton, S., Collard, C. D., Riedel, B., & Warltier, D. C. (2006) · Anesthesiology · doi:10.1097/00000542-200612000-00027 · Cited by 291
Zoonotic Potential of Influenza A Viruses: A Comprehensive Overview
Mostafa, A., Abdelwhab, E. M., Mettenleiter, T. C., & Pleschka, S. (2018) · Viruses · doi:10.3390/v10090497 · Cited by 290
Quality-of-life and spirituality
Panzini, R. G., Mosqueiro, B. P., Zimpel, R. R., Bandeira, D. R., Rocha, N. S., & Fleck, M. P. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1285553 · Cited by 289
Qualidade de vida e espiritualidade
Panzini, R. G., Rocha, N. S. D., Bandeira, D. R., & Fleck, M. P. D. A. (2007) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832007000700014 · Cited by 288
Mechanistic Studies on Metabolic Interactions between Gemfibrozil and Statins
Prueksaritanont, T., Zhao, J. J., Ma, B., Roadcap, B. A., Tang, C., Qiu, Y., Liu, L., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.301.3.1042 · Cited by 287
Current overview of statin-induced myopathy
Rosenson, R. S. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.10.033 · Cited by 287
Garfield, S., Clifford, S., Eliasson, L., Barber, N., & Willson, A. (2011) · BMC Medical Research Methodology · doi:10.1186/1471-2288-11-149 · Cited by 286
Validation of the ‘Test of the Adherence to Inhalers’ (TAI) for Asthma and COPD Patients
Plaza, V., Fernández-Rodríguez, C., Melero, C., Cosío, B. G., Entrenas, L. M., de Llano, L. P., Gutiérrez-Pereyra, F., Tarragona, E., Palomino, R., López-Viña, A., et al. (2016) · Journal of Aerosol Medicine and Pulmonary Drug Delivery · doi:10.1089/jamp.2015.1212 · Cited by 284
Psychosocial issues in adolescents with cancer
Abrams, A. N., Hazen, E. P., & Penson, R. T. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.12.006 · Cited by 283
McElroy, S. L., Hudson, J. I., Capece, J. A., Beyers, K., Fisher, A. C., & Rosenthal, N. R. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.08.008 · Cited by 281
Outcomes in 45 Patients With Statin-Associated Myopathy
Hansen, K. E., Hildebrand, J. P., Ferguson, E. E., & Stein, J. H. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2671 · Cited by 280
Bile Acid Metabolism and Signaling
Chiang, J. Y. L. (2013) · Comprehensive Physiology · doi:10.1002/j.2040-4603.2013.tb00517.x · Cited by 279
Nature of preventable adverse drug events in hospitals: a literature review
Kanjanarat, P., Winterstein, A. G., Johns, T. E., Hatton, R. C., Gonzalez-Rothi, R., & Segal, R. (2003) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/60.17.1750 · Cited by 277
A review of the receptor-binding and pharmacokinetic properties of dopamine agonists
Kvernmo, T., Härtter, S., & Burger, E. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.08.004 · Cited by 277
Bernard, S., Neville, K. A., Nguyen, A. T., & Flockhart, D. A. (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-126 · Cited by 277
Diabetes self-management education core outcomes measures
Mulcahy, K., Maryniuk, M., Peeples, M., Peyrot, M., Tomky, D., Weaver, T., & Yarborough, P. (2003) · The Diabetes Educator · doi:10.1177/014572170302900509 · Cited by 273
Schnell, K., Weiss, C. O., Lee, T., Krishnan, J. A., Leff, B., Wolff, J. L., & Boyd, C. (2012) · BMC Pulmonary Medicine · doi:10.1186/1471-2466-12-26 · Cited by 274
Peeters, J., Neeskens, P., Tollenaere, J. P., Van Remoortere, P., & Brewster, M. E. (2002) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.10126 · Cited by 272
Wilby, J., Kainth, A., Hawkins, N., Epstein, D., McIntosh, H., McDaid, C., Mason, A., Golder, S., O'Meara, S., Sculpher, M., et al. (2005) · Health Technology Assessment · doi:10.3310/hta9150 · Cited by 271
PALINSKI, W., & NAPOLI, C. (2002) · The FASEB Journal · doi:10.1096/fj.02-0226rev · Cited by 268
Lai, S.-W., Liao, K.-F., Liao, C.-C., Muo, C.-H., Liu, C.-S., & Sung, F.-C. (2010) · Medicine · doi:10.1097/md.0b013e3181f15efc · Cited by 268
Statins and hepatotoxicity: Focus on patients with fatty liver†
Chalasani, N. (2005) · Hepatology · doi:10.1002/hep.20671 · Cited by 265
Medication Adherence to Multidrug Regimens
Marcum, Z. A., & Gellad, W. F. (2012) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2012.01.008 · Cited by 264
Update on neuropharmacological treatments for alcoholism: Scientific basis and clinical findings
Johnson, B. A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.08.005 · Cited by 264
Treatment with thyroid hormone
Biondi, B., & Wartofsky, L. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1083 · Cited by 259
Dwoskin, L. P., Rauhut, A. S., King‐Pospisil, K. A., & Bardo, M. T. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00178.x · Cited by 259
An Assessment of Statin Safety by Muscle Experts
Thompson, P. D., Clarkson, P. M., & Rosenson, R. S. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.013 · Cited by 259
Toxicity of Ammonium Perfluorooctanoate in Male Cynomolgus Monkeys after Oral Dosing for 6 Months
Butenhoff, J. (2002) · Toxicological Sciences · doi:10.1093/toxsci/69.1.244 · Cited by 259
Practice-Based Evidence Study Design for Comparative Effectiveness Research
Horn, S. D., & Gassaway, J. (2007) · Medical Care · doi:10.1097/mlr.0b013e318070c07b · Cited by 257
Bender, B. G., & Bender, S. E. (2005) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.09.005 · Cited by 256
Hansen, R. A., Gartlehner, G., Lohr, K. N., Gaynes, B. N., & Carey, T. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-143-6-200509200-00006 · Cited by 255
Genetic risk factors associated with lipid-lowering drug-induced myopathies
Vladutiu, G. D., Simmons, Z., Isackson, P. J., Tarnopolsky, M., Peltier, W. L., Barboi, A. C., Sripathi, N., Wortmann, R. L., & Phillips, P. S. (2006) · Muscle & Nerve · doi:10.1002/mus.20567 · Cited by 253
Haider, S. I., Johnell, K., Weitoft, G. R., Thorslund, M., & Fastbom, J. (2009) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2008.02040.x · Cited by 253
Restless Legs Syndrome, Periodic Limb Movements in Sleep, and Depression
(2005) · Sleep · doi:10.1093/sleep/28.7.891 · Cited by 247
Are Spirituality and Religiosity Resources for Patients with Chronic Pain Conditions?
Büssing, A., Michalsen, A., Balzat, H.-J., Grünther, R.-A., Ostermann, T., Neugebauer, E. A. M., & Matthiessen, P. F. (2009) · Pain Medicine · doi:10.1111/j.1526-4637.2009.00572.x · Cited by 227
Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce cardiovascular risk
Chapman, M. J., Redfern, J. S., McGovern, M. E., & Giral, P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.01.008 · Cited by 227
Conditions and drugs interfering with thyroxine absorption
Liwanpo, L., & Hershman, J. M. (2009) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2009.06.006 · Cited by 222
Coping (enfrentamento) religioso/espiritual
Panzini, R. G., & Bandeira, D. R. (2007) · Archives of Clinical Psychiatry (São Paulo) · doi:10.1590/s0101-60832007000700016 · Cited by 220
Medication Adherence in Older Adults With Cognitive Impairment: A Systematic Evidence-Based Review
Campbell, N. L., Boustani, M. A., Skopelja, E. N., Gao, S., Unverzagt, F. W., & Murray, M. D. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2012.04.004 · Cited by 206
Low levels of circulating inflammatory cytokines—Do they affect human brain functions?
Pollmächer, T., Haack, M., Schuld, A., Reichenberg, A., & Yirmiya, R. (2002) · Brain, Behavior, and Immunity · doi:10.1016/s0889-1591(02)00004-1 · Cited by 202
Messina, M., & Redmond, G. (2006) · Thyroid · doi:10.1089/thy.2006.16.249 · Cited by 200
Timing of levothyroxine administration affects serum thyrotropin concentration
Bach-Huynh, T.-G., Nayak, B., Loh, J., Soldin, S., & Jonklaas, J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0860 · Cited by 198
George, J., Elliott, R. A., & Stewart, D. C. (2008) · Drugs & Aging · doi:10.2165/00002512-200825040-00004 · Cited by 191
Cardiovascular drug therapy in the elderly: benefits and challenges
Fleg, J. L., Aronow, W. S., & Frishman, W. H. (2011) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2010.162 · Cited by 186
A Comparison of the Risk of QT Prolongation Among SSRIs
Funk, K. A., & Bostwick, J. R. (2013) · Annals of Pharmacotherapy · doi:10.1177/1060028013501994 · Cited by 174
A review of the pharmacokinetics of levothyroxine for the treatment of hypothyroidism
Colucci, P., Yue, C. S., Ducharme, M., Benvenga, S., Principal Scientist, L. A. C. I., Principal Scientist, L. A. C. I. A. P. C., President and CEO, L. A. C. I., & Professor of Medicine, D. (2010) · European Endocrinology · doi:10.17925/ee.2013.09.01.40 · Cited by 167
Cardiovascular side-effects of antipsychotic drugs: The role of the autonomic nervous system
Leung, J. Y. T., Barr, A. M., Procyshyn, R. M., Honer, W. G., & Pang, C. C. Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.04.003 · Cited by 163
Reichenpfader, U., Gartlehner, G., Morgan, L. C., Greenblatt, A., Nussbaumer, B., Hansen, R. A., Van Noord, M., Lux, L., & Gaynes, B. N. (2014) · Drug Safety · doi:10.1007/s40264-013-0129-4 · Cited by 160
Kaneko, N., Kudo, K., Mabuchi, T., Takemoto, K., Fujimaki, K., Wati, H., Iguchi, H., Tezuka, H., & Kanba, S. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301137 · Cited by 152
“…high-dose administration of IFN-a has been noted to be frequently associated with various neuropsychiatric adverse effects, such as insomnia, agitation, cognitive dysfunction, depression, and memory disturbance (Capuron et al, 2002; Dieperink et al, 2000; Horikawa et al, 2003; Malek-Ahmadi 2001).”
Second-Generation Antipsychotic Medications in Children and Adolescents
Cheng-Shannon, J., McGough, J. J., Pataki, C., & McCracken, J. T. (2004) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2004.14.372 · Cited by 152
Horikawa, N., Yamazaki, T., Izumi, N., & Uchihara, M. (2003) · General Hospital Psychiatry · doi:10.1016/s0163-8343(02)00239-6 · Cited by 140
Hong, F., Xu, P., & Zhai, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082189 · Cited by 139
Effect of Fibrates on Lipid Profiles and Cardiovascular Outcomes: A Systematic Review
Abourbih, S., Filion, K. B., Joseph, L., Schiffrin, E. L., Rinfret, S., Poirier, P., Pilote, L., Genest, J., & Eisenberg, M. J. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.03.030 · Cited by 139
Factors Affecting Gastrointestinal Absorption of Levothyroxine: A Review
Skelin, M., Lucijanić, T., Amidžić Klarić, D., Rešić, A., Bakula, M., Liberati-Čizmek, A.-M., Gharib, H., & Rahelić, D. (2017) · Clinical Therapeutics · doi:10.1016/j.clinthera.2017.01.005 · Cited by 133
Meta‐analysis: proton‐pump inhibition in high‐risk patients with acute peptic ulcer bleeding
Bardou, M., Toubouti, Y., Benhaberou‐Brun, D., Rahme, E., & Barkun, A. N. (2005) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2005.02391.x · Cited by 132
Effects of Evening vs Morning Levothyroxine Intake: A Randomized Double-blind Crossover Trial
Bolk, N. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.436 · Cited by 128
Konovalov, S., Muralee, S., & Tampi, R. R. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207006540 · Cited by 126
The role of fibrates in managing hyperlipidemia: Mechanisms of action and clinical efficacy
Fazio, S., & Linton, M. F. (2004) · Current Atherosclerosis Reports · doi:10.1007/s11883-004-0104-8 · Cited by 118
Can, A., Zanos, P., Moaddel, R., Kang, H. J., Dossou, K. S. S., Wainer, I. W., Cheer, J. F., Frost, D. O., Huang, X.-P., & Gould, T. D. (2016) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.235838 · Cited by 115
Acid Suppression Therapy: Where Do We Go from Here?
Scarpignato, C., Pelosini, I., & Di Mario, F. (2006) · Digestive Diseases · doi:10.1159/000091298 · Cited by 119
Simvastatin induces impairment in skeletal muscle while heart is protected
Sirvent, P., Bordenave, S., Vermaelen, M., Roels, B., Vassort, G., Mercier, J., Raynaud, E., & Lacampagne, A. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.108 · Cited by 116
Age and Sex Patterns of Drug Prescribing in a Defined American Population
Zhong, W., Maradit-Kremers, H., St. Sauver, J. L., Yawn, B. P., Ebbert, J. O., Roger, V. L., Jacobson, D. J., McGree, M. E., Brue, S. M., & Rocca, W. A. (2013) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2013.04.021 · Cited by 116
Scott, I. A., Pillans, P. I., Barras, M., & Morris, C. (2018) · Therapeutic Advances in Drug Safety · doi:10.1177/2042098618784809 · Cited by 114
Nutritional Interventions in the Management of Fibromyalgia Syndrome
Pagliai, G., Giangrandi, I., Dinu, M., Sofi, F., & Colombini, B. (2020) · Nutrients · doi:10.3390/nu12092525 · Cited by 113
Statin safety: an appraisal from the adverse event reporting system
Davidson, M. H., Clark, J. A., Glass, L. M., & Kanumalla, A. (2006) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.12.008 · Cited by 113
Ravindran, A. V., Lam, R. W., Filteau, M. J., Lespérance, F., Kennedy, S. H., Parikh, S. V., & Patten, S. B. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.040 · Cited by 108
Stein, E. A., Ballantyne, C. M., Windler, E., Sirnes, P. A., Sussekov, A., Yigit, Z., Seper, C., & Gimpelewicz, C. R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.09.099 · Cited by 102
A review of interventions used to improve adherence to medication in older people
Banning, M. (2009) · International Journal of Nursing Studies · doi:10.1016/j.ijnurstu.2009.03.011 · Cited by 98
Schlenk, E. A., Dunbar-Jacob, J., & Engberg, S. (2004) · Journal of Gerontological Nursing · doi:10.3928/0098-9134-20040701-08 · Cited by 95
Natural Health Product Interactions with Medication
Boullata, J. I. (2005) · Nutrition in Clinical Practice · doi:10.1177/011542650502000133 · Cited by 95
Management of inappropriate sexual behaviors in dementia: a literature review
Tucker, I. (2010) · International Psychogeriatrics · doi:10.1017/s1041610210000189 · Cited by 91
Levothyroxine Replacement Doses Are Affected by Gender and Weight, But Not Age
Devdhar, M., Drooger, R., Pehlivanova, M., Singh, G., & Jonklaas, J. (2011) · Thyroid · doi:10.1089/thy.2011.0029 · Cited by 90
l-Thyroxine Requirement in Patients with Autoimmune Hypothyroidism and Parietal Cell Antibodies
Checchi, S., Montanaro, A., Pasqui, L., Ciuoli, C., De Palo, V., Chiappetta, M. C., & Pacini, F. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1544 · Cited by 89
Optimal thyroid hormone replacement
Jonklaas, J. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab031 · Cited by 89
Panzini, R. G., Maganha, C., Rocha, N. S. D., Bandeira, D. R., & Fleck, M. P. (2011) · Revista de Saúde Pública · doi:10.1590/s0034-89102011000100018 · Cited by 113
Diagnosis and treatment of levothyroxine pseudomalabsorption.
Lips, D. J., Reisen, M. V., Voigt, V., & Venekamp, W. J. R. R. (2004) · PubMed · Cited by 87
Levothyroxine interactions with food and dietary supplements – a systematic review
Wiesner, A., Gajewska, D., & Paśko, P. (2021) · Pharmaceuticals · doi:10.3390/ph14030206 · Cited by 85
“…of treatment cannot be made due to the insufficient evidence advise to avoid excessive intake Calcium (carbonate, acetate, citrate) case reports [81–83], case series [80], retrospective cohort studies [11,84,86], prospective cohort study [77], uncontrolled clinical study [87], non ‐ randomized…”
BackgroundMyopathy with statin–fibrate combination therapy: clinical considerations
Jacobson, T. A. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.151 · Cited by 82
Prevalence and risk factors of muscle complications secondary to statins
El‐Salem, K., Ababneh, B., Rudnicki, S., Malkawi, A., Alrefai, A., Khader, Y., Saadeh, R., & Saydam, M. (2011) · Muscle & Nerve · doi:10.1002/mus.22205 · Cited by 83
The safety of HMG-CoA reductase inhibitors in special populations at high cardiovascular risk
Corsini, A. (2003) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1026132412074 · Cited by 82
Cerebrospinal fluid interleukin (IL)-6 in unipolar major depression
Carpenter, L. L., Heninger, G. R., Malison, R. T., Tyrka, A. R., & Price, L. H. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(02)00460-3 · Cited by 79
Nattokinase improves blood flow by inhibiting platelet aggregation and thrombus formation
Jang, J.-Y., Kim, T.-S., Cai, J., Kim, J., Kim, Y., Shin, K., Kim, K. S., Park, S. K., Lee, S.-P., Choi, E.-K., et al. (2013) · Laboratory Animal Research · doi:10.5625/lar.2013.29.4.221 · Cited by 77
Religiosity and Self-Rated Health among Latin American and Caribbean Elders
Reyes-Ortiz, C. A., Pelaez, M., Koenig, H. G., & Mulligan, T. (2007) · The International Journal of Psychiatry in Medicine · doi:10.2190/pm.37.4.f · Cited by 77
Self-citationQuantifying bile acid malabsorption helps predict response and tailor sequestrant therapy
Orekoya, O., McLaughlin, J., Leitao, E., Johns, W., Lal, S., & Paine, P. (2015) · Clinical Medicine · doi:10.7861/clinmedicine.15-3-252 · Cited by 74
Sex and Age Differences in Levothyroxine Dosage Requirement
Jonklaas, J. (2010) · Endocrine Practice · doi:10.4158/ep09257.or · Cited by 72
Medication Adherence Among Geriatric Outpatients Prescribed Multiple Medications
Tsai, K.-T., Chen, J.-H., Wen, C.-J., Kuo, H.-K., Lu, I.-S., Chiu, L.-S., Wu, S.-C., & Chan, D.-C. (2012) · The American Journal of Geriatric Pharmacotherapy · doi:10.1016/j.amjopharm.2011.11.005 · Cited by 67
Effect of Antipsychotic Medications on Glucose and Lipid Levels
Chaggar, P. S., Shaw, S. M., & Williams, S. G. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270010368678 · Cited by 65
The challenges of using medication event monitoring technology with pediatric transplant patients
Shellmer, D. A., & Zelikovsky, N. (2007) · Pediatric Transplantation · doi:10.1111/j.1399-3046.2007.00681.x · Cited by 65
Tsamandouras, N., Dickinson, G., Guo, Y., Hall, S., Rostami-Hodjegan, A., Galetin, A., & Aarons, L. (2015) · Pharmaceutical Research · doi:10.1007/s11095-014-1581-2 · Cited by 64
Levothyroxine: conventional and novel drug delivery formulations.
Liu, H., Li, W., Zhang, W., Sun, S., & Chen, C. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnac030 · Cited by 63
Graff, S. K., Mario, F. M., Ziegelmann, P., & Spritzer, P. M. (2016) · International Journal of Clinical Practice · doi:10.1111/ijcp.12787 · Cited by 63
Risk factors for medication nonadherence in older adults with cognitive impairment who live alone
Thiruchselvam, T., Naglie, G., Moineddin, R., Charles, J., Orlando, L., Jaglal, S., Snow, W., & Tierney, M. C. (2012) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3778 · Cited by 58
Late-Life Onset Hypogonadism: A Review
Bassil, N., & Morley, J. E. (2010) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2010.02.003 · Cited by 59
Metadata
- Authors
- Csako, G., McGriff, N. J., Rotman-Pikielny, P., Sarlis, N. J., & Pucino, F.
- Affiliations
- Gyorgy Csako MD, Assistant Chief of Clinical Chemistry, Department of Laboratory Medicine, Warren G Magnuson Clinical Center, National Institutes of Health, Bethesda, MD
- Nayahmka J McGriff PharmD, at time of writing, Primary Care Resident, Pharmacy Department, Warren G Magnuson Clinical Center; now, Assistant Professor, Department of Pharmacy Practice and Administration, University of the Sciences, Philadelphia, PA
- Pnina Rotman-Pikielny MD, Clinical Fellow, Clinical Endocrinology Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health
- National Institutes of Health (US)
- Venue
- Annals of Pharmacotherapy
- Publisher
- SAGE Publications
- Published
- 2001-12
- Volume
- 35
- Issue
- 12
- Pages
- 1578-1583
- ISSN
- 0012-6578 (ISSN-L)
- 1060-0280
- 1542-6270
- OpenAlex
- W2120448580
- Cited by
- 40
- References
- 26
- Citations by year
- 2026: 1 · 2023: 2 · 2022: 1 · 2021: 3 · 2019: 1 · 2018: 1 · 2016: 1 · 2015: 2 · 2014: 1 · 2013: 1
- FWCI
- 1.84
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
- Locations
- Annals of Pharmacotherapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Thyroid Disorders and Treatments
- Health Sciences › Medicine › Surgery › Thyroid and Parathyroid Surgery
- Health Sciences › Medicine › Gastroenterology › Celiac Disease Research and Management
- Keywords
- calcium carbonate, drug interactions, primary hypothyroidism, thyroid-stimulating hormone, timing of drug administration, celiac disease, systemic lupus erythematosus, Whipple resection, pancreatic cancer, gastrointestinal diseases, thyroid hormone absorption
- MeSH terms
- Antacids, Calcium Carbonate, Celiac Disease, Female, Humans, Hypothyroidism, Intestinal Absorption, Lupus Erythematosus, Systemic, Malabsorption Syndromes, Middle Aged, Thyrotropin, Thyroxine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.